Singapore state investor Temasek has backed the £195 million ($271 million) funding round in Nanopore Technologies, a UK-headquartered DNA sequencing firm that plans to go public later this year, according to an announcement.
Nanopore, which has been valued at about $3.44 billion after the funding round, announced that new investors Temasek, Wellington Management, M&G Investments, and Nikon have invested a combined £125 million into the life sciences company while existing investors poured in £70 million.
